Kirong, Baby Boy .

HRN: 23-05-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2023
AMPICILLIN 250MG (VIAL)
06/07/2023
06/13/2023
IVT
105mg
Q12hrs
Thickly MSAF, PROM X 16hrs
Waiting Final Action 
06/07/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
06/07/2023
06/13/2023
IV
10.5
Od
Thickly MSAF; PROM X 16hrs
Waiting Final Action 
06/09/2023
CEFTAZIDIME 1GM (VIAL)
06/09/2023
06/15/2023
IVT
105
Q12
Psnb
Waiting Final Action 
06/09/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/09/2023
06/15/2023
IVT
32mg
Q24
Psnb
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: